Keyphrases
Platelets
93%
Imipramine
86%
VMAT2
51%
High Affinity
41%
Rat Brain
41%
Binding Site
39%
Serotonin Transporter
37%
Vesicular Monoamine Transporter
33%
Antidepressants
32%
Serotonin Uptake
28%
Tricyclic Antidepressants
25%
Selective Serotonin Reuptake Inhibitors
23%
Human Platelets
21%
Amphetamine
20%
Monoamines
16%
Herbal Treatment
16%
Striatal
13%
Striatum
13%
Serum Serotonin
13%
Schizophrenic Patients
12%
Methylphenidate
12%
High-affinity Binding Site
12%
Bmax
12%
Dopamine
11%
Human Lymphoblastoid Cell Lines
11%
Dihydrotetrabenazine
11%
Serotonin
11%
Prefrontal Cortex
10%
Verapamil
10%
Dopamine Transporter
10%
Synaptic Vesicle
10%
Schizophrenia
10%
Major Depressive Disorder
10%
Brain-derived Neurotrophic Factor
10%
Antimuscarinics
10%
Lymphocytes
9%
5-hydroxytryptamine
9%
Depressed Patients
9%
Escitalopram
9%
Psychostimulants
9%
Rasagiline
8%
Thiamine Deficiency
8%
Modulatory Effects
8%
Hyperforin
8%
Cocaine
8%
Thiamine
8%
Paroxetine
8%
Human Brain
8%
Platelet Membrane
7%
Serotonergic System
7%
Neuroscience
Platelet
100%
Imipramine
77%
Vesicular Monoamine Transporter 2
44%
Binding Site
39%
Serotonin Transporter
34%
Antidepressant
32%
Vesicular Monoamine Transporter
30%
Serotonin Uptake
29%
Tricyclic Antidepressant
22%
Dopaminergic
20%
Selective Serotonin Reuptake Inhibitor
20%
Amphetamine
17%
Monoamine
17%
Serotonin
17%
Behavior (Neuroscience)
17%
Striatum
16%
Brain-Derived Neurotrophic Factor
14%
In Vitro
13%
Cell Line
13%
Escitalopram
12%
Prefrontal Cortex
11%
Lymphocyte
11%
Attention Deficit Hyperactivity Disorder
11%
Mouse Brain
11%
Serotonergic
10%
Methylphenidate
10%
Synaptic Vesicle
10%
In Vivo
9%
Dopamine Transporter
9%
Receptor
9%
Major Depressive Disorder
8%
Rasagiline
8%
Hyperforin
8%
Thiamine
8%
Messenger RNA
8%
Psychostimulant
8%
Verapamil
8%
Anxiety Disorder
7%
Obsessive-Compulsive Disorder
7%
Haloperidol
7%
Clozapine
6%
Cholinergic
6%
Desipramine
6%
Reuptake
6%
Hypothalamus
6%
Muscarinic Acetylcholine Receptor
6%
Nucleus Accumbens
6%
Citalopram
6%
Amitriptyline
5%
Paroxetine
5%
